Evidence map›Paper›PMID 40573252›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Real-World Analysis of Short-Term Effectiveness of Oral Semaglutide: Impact on Glycometabolic Control and Cardiovascular Risk.

Sara Palazzi, Federica Sentinelli, Antonella Zugaro, Sara Morgante, Livia Santarelli, Sandra Melanzi, Annamaria De Mutiis, Deamaria Piersanti, Barbara Macerola, Marco Iezzi and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sara PalazziDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.
Federica SentinelliDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.
Antonella ZugaroUOSD Diabetology, San Salvatore Hospital, ASL1 Abruzzo, 67100 L'Aquila, Italy.
Sara MorganteUOSD Diabetology, San Salvatore Hospital, ASL1 Abruzzo, 67100 L'Aquila, Italy.
Livia SantarelliUOSD Diabetology, PO Castel di Sangro-Sulmona, ASL1 Abruzzo, 67031 L'Aquila, Italy.
Sandra MelanziUOSD Diabetology, PO Castel di Sangro-Sulmona, ASL1 Abruzzo, 67031 L'Aquila, Italy.
Annamaria De MutiisUOSD Diabetology, PO Castel di Sangro-Sulmona, ASL1 Abruzzo, 67031 L'Aquila, Italy.
Deamaria PiersantiUOSD Diabetology, POAvezzano, ASL1 Abruzzo, 67051 L'Aquila, Italy.
Barbara MacerolaUOSD Diabetology, POAvezzano, ASL1 Abruzzo, 67051 L'Aquila, Italy.
Marco IezziUOSD Diabetology, POAvezzano, ASL1 Abruzzo, 67051 L'Aquila, Italy.
Pietro MercuriUOSD Diabetology, POAvezzano, ASL1 Abruzzo, 67051 L'Aquila, Italy.
Alessandro FerrantiDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.
Daniele TienfortiDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-9359-7955
Maria Gisella CavalloDepartment of Experimental Medicine, Sapienza University, 00185 Rome, Italy.ORCID 0000-0001-6630-8049
Arcangelo BarbonettiDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-6888-9585
Marco Giorgio BaroniDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-3224-6078

Funding

Horizon EU4Health Programme (EU4H) 101128983 - PROVIDEItalian Ministry of the University PRIN PNRR 2022 P20222CB2BMinistero della Salute PNRR-MAD-2022- 12375970
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BMIduration of diabetesGLP1-receptor agonistHbA1ctype 2 diabetesweight

Identifiers

PMID40573252
PMCPMC12195834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.